114 related articles for article (PubMed ID: 38933247)
1. MT2 INHIBITS OSTEOCLASTOGENESIS BY SCAVENGING ROS.
Wei S; Liu K; Wu H; Hu J; He J; Li G; Liu B; Yang W
Acta Endocrinol (Buchar); 2023; 19(4):447-455. PubMed ID: 38933247
[TBL] [Abstract][Full Text] [Related]
2. Curcumin inhibits the migration of osteoclast precursors and osteoclastogenesis by repressing CCL3 production.
Liang Z; Xue Y; Wang T; Xie Q; Lin J; Wang Y
BMC Complement Med Ther; 2020 Jul; 20(1):234. PubMed ID: 32703287
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-17 prevents oxidative stress from damaging osteoblast formation by inhibiting autophagic degradation of metallothionein-2.
Ling X; Wang C; Feng Q; Zhang T
Endocr J; 2024 Jun; 71(6):623-633. PubMed ID: 38644219
[TBL] [Abstract][Full Text] [Related]
4. Curcumin suppresses RANKL-induced osteoclast precursor autophagy in osteoclastogenesis by inhibiting RANK signaling and downstream JNK-BCL2-Beclin1 pathway.
Ke D; Xu H; Han J; Dai H; Wang X; Luo J; Yu Y; Xu J
Biomed J; 2024 Feb; 47(1):100605. PubMed ID: 37179010
[TBL] [Abstract][Full Text] [Related]
5. TNF Induction of NF-κB RelB Enhances RANKL-Induced Osteoclastogenesis by Promoting Inflammatory Macrophage Differentiation but also Limits It through Suppression of NFATc1 Expression.
Zhao Z; Hou X; Yin X; Li Y; Duan R; Boyce BF; Yao Z
PLoS One; 2015; 10(8):e0135728. PubMed ID: 26287732
[TBL] [Abstract][Full Text] [Related]
6. Pseurotin A Inhibits Osteoclastogenesis and Prevents Ovariectomized-Induced Bone Loss by Suppressing Reactive Oxygen Species.
Chen K; Qiu P; Yuan Y; Zheng L; He J; Wang C; Guo Q; Kenny J; Liu Q; Zhao J; Chen J; Tickner J; Fan S; Lin X; Xu J
Theranostics; 2019; 9(6):1634-1650. PubMed ID: 31037128
[No Abstract] [Full Text] [Related]
7. Melatonin at pharmacological concentrations suppresses osteoclastogenesis via the attenuation of intracellular ROS.
Zhou L; Chen X; Yan J; Li M; Liu T; Zhu C; Pan G; Guo Q; Yang H; Pei M; He F
Osteoporos Int; 2017 Dec; 28(12):3325-3337. PubMed ID: 28956094
[TBL] [Abstract][Full Text] [Related]
8. A novel RANKL-targeted flavonoid glycoside prevents osteoporosis through inhibiting NFATc1 and reactive oxygen species.
Hong G; Chen Z; Han X; Zhou L; Pang F; Wu R; Shen Y; He X; Hong Z; Li Z; He W; Wei Q
Clin Transl Med; 2021 May; 11(5):e392. PubMed ID: 34047464
[TBL] [Abstract][Full Text] [Related]
9. ED-71 inhibited osteoclastogenesis by enhancing EphrinB2-EphB4 signaling between osteoclasts and osteoblasts in osteoporosis.
Zhang Y; Kou Y; Yang P; Rong X; Tang R; Liu H; Li M
Cell Signal; 2022 Aug; 96():110376. PubMed ID: 35690294
[TBL] [Abstract][Full Text] [Related]
10. Xanthotoxin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis.
Dou C; Chen Y; Ding N; Li N; Jiang H; Zhao C; Kang F; Cao Z; Quan H; Luo F; Xu J; Dong S
Osteoporos Int; 2016 Jul; 27(7):2335-2344. PubMed ID: 26809192
[TBL] [Abstract][Full Text] [Related]
11. Low‑frequency pulsed electromagnetic field inhibits RANKL‑induced osteoclastic differentiation in RAW264.7 cells by scavenging reactive oxygen species.
Pi Y; Liang H; Yu Q; Yin Y; Xu H; Lei Y; Han Z; Tian J
Mol Med Rep; 2019 May; 19(5):4129-4136. PubMed ID: 30942408
[TBL] [Abstract][Full Text] [Related]
12. Thymoquinone prevents RANKL-induced osteoclastogenesis activation and osteolysis in an in vivo model of inflammation by suppressing NF-KB and MAPK Signalling.
Thummuri D; Jeengar MK; Shrivastava S; Nemani H; Ramavat RN; Chaudhari P; Naidu VG
Pharmacol Res; 2015 Sep; 99():63-73. PubMed ID: 26022736
[TBL] [Abstract][Full Text] [Related]
13. Guizhi Shaoyao Zhimu granules attenuate bone destruction in mice with collagen-induced arthritis by promoting mitophagy of osteoclast precursors to inhibit osteoclastogenesis.
Yao H; Xiang L; Huang Y; Tan J; Shen Y; Li F; Geng F; Liu W; Li X; Gao Y
Phytomedicine; 2023 Sep; 118():154967. PubMed ID: 37490802
[TBL] [Abstract][Full Text] [Related]
14. The Roles of ROS Generation in RANKL-Induced Osteoclastogenesis: Suppressive Effects of Febuxostat.
Ashtar M; Tenshin H; Teramachi J; Bat-Erdene A; Hiasa M; Oda A; Tanimoto K; Shimizu S; Higa Y; Harada T; Oura M; Sogabe K; Nakamura S; Fujii S; Sumitani R; Miki H; Udaka K; Takahashi M; Kagawa K; Endo I; Tanaka E; Matsumoto T; Abe M
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32283857
[TBL] [Abstract][Full Text] [Related]
15. The synergistic effects of Sr and Si bioactive ions on osteogenesis, osteoclastogenesis and angiogenesis for osteoporotic bone regeneration.
Mao L; Xia L; Chang J; Liu J; Jiang L; Wu C; Fang B
Acta Biomater; 2017 Oct; 61():217-232. PubMed ID: 28807800
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of BCL2 at the Ser70 site mediates RANKL-induced osteoclast precursor autophagy and osteoclastogenesis.
Ke D; Yu Y; Li C; Han J; Xu J
Mol Med; 2022 Feb; 28(1):22. PubMed ID: 35183115
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of a prominent dihydroxyflavanone pinocembrin for osteolytic bone disease:
Hong G; Li S; Zheng G; Zheng X; Zhan Q; Zhou L; Wei Q; He W; Chen Z
J Orthop Translat; 2024 Mar; 45():197-210. PubMed ID: 38685969
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin inhibits osteoclast differentiation by scavenging reactive oxygen species.
Moon HJ; Kim SE; Yun YP; Hwang YS; Bang JB; Park JH; Kwon IK
Exp Mol Med; 2011 Nov; 43(11):605-12. PubMed ID: 21832867
[TBL] [Abstract][Full Text] [Related]
19. 1-2 T static magnetic field combined with Ferumoxytol prevent unloading-induced bone loss by regulating iron metabolism in osteoclastogenesis.
Zhang G; Zhen C; Yang J; Zhang Z; Wu Y; Che J; Shang P
J Orthop Translat; 2023 Jan; 38():126-140. PubMed ID: 36381248
[TBL] [Abstract][Full Text] [Related]
20. Dauricine attenuates ovariectomized-induced bone loss and RANKL-induced osteoclastogenesis via inhibiting ROS-mediated NF-κB and NFATc1 activity.
Lin X; Yuan G; Yang B; Xie C; Zhou Z; Liu Y; Liu Z; Wu Z; Akimoto Y; Li N; Xu R; Song F
Phytomedicine; 2024 Jul; 129():155559. PubMed ID: 38579642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
